Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing

Abstract

Genome editing with the CRISPR-CRISPR-associated 9 system disrupts the Pcsk9 gene in vivo with high efficiency and reduces blood cholesterol levels in mice. This approach may have therapeutic potential for the prevention of cardiovascular disease in humans.